Portable Oxygen Concentrators Market Size, Share and Forecast 2026-2034

Market Overview:

According to IMARC Group's latest research publication, "Portable Oxygen Concentrators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034", The global portable oxygen concentrators market size was valued at USD 2.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 3.6 Billion by 2034, exhibiting a CAGR of 6.62% from 2026-2034.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How Portable Oxygen Concentrators Are Reshaping the Global Respiratory Care Market

• North America currently dominates the market with a significant share of over 38.9% in 2025, driven by high prevalence of chronic respiratory diseases, advanced healthcare infrastructure, and strong Medicare reimbursement policies. 
• Pulse flow technology leads the technology segment with 69.5% of the market share in 2025, valued for its synchronized oxygen delivery, lightweight design, and superior portability suited to active patients. 
• COPD accounts for 43.2% of the application segment, as patients with this chronic condition require prolonged supplemental oxygen therapy, making portable devices essential for maintaining mobility and quality of life. 
• In November 2024, the Indian government launched a Rs 500 crore initiative to strengthen its medical devices industry, focusing on boosting local production of devices including oxygen concentrators, reducing import dependency, and funding clinical studies, with the goal of making India a key player in the global medical devices market projected to grow to USD 30 billion by 2030. 
• In June 2024, Inogen published a study in Pulmonary Therapy, drawing on data from 244,000 patients, confirming that portable oxygen concentrators improve survival rates and reduce costs compared to other oxygen therapy methods. 

Download a sample PDF of this report:   https://www.imarcgroup.com/portable-oxygen-concentrators-market/requestsample

Key Trends in the Portable Oxygen Concentrators Market

• Surging Burden of Chronic Respiratory Diseases: According to the WHO, an estimated 545 million people suffer from chronic respiratory diseases including COPD, asthma, and pulmonary fibrosis, forming a vast potential patient base for oxygen therapy.  This scale of disease burden directly underpins rising demand for portable, patient-friendly oxygen delivery devices across both developed and emerging markets.
• Accelerating Shift Toward Home-Based Medical Care: According to the European Respiratory Society, 60% of patients with chronic respiratory diseases prefer to be cared for at home rather than in a hospital, citing convenience and comfort as the primary factors.  This preference is reshaping procurement strategies as manufacturers develop POCs specifically tailored to home use environments, with extended battery life and user-friendly interfaces.
• Smart Technology Integration Gaining Momentum: Manufacturers are embedding Bluetooth connectivity, app-based monitoring, and real-time adjustment capabilities into POC devices. In October 2024, Inogen Inc. The portable oxygen concentrator market is growing due to rising respiratory disease prevalence, aging populations, and demand for home-based oxygen therapy solutions. introduced the Rove 4 Portable Oxygen Concentrator, featuring a fourth flow setting that delivers 840 ml/min of oxygen and offers up to 5.75 hours of operation, enhancing ambulatory oxygen therapy for patients. 
• Government Schemes Widening Market Access: Saudi Arabia dedicated USD 5 Billion in 2023 for health sector modernization under Vision 2030, which included the procurement of oxygen concentrators and other health products.  Similarly, Mexico's Seguro Popular program offers subsidies to increase adoption rates of oxygen concentrators within Latin America.  These government-backed programs are significantly lowering financial barriers to access.
• Personalized Oxygen Prescriptions Driving Device Complexity in Europe: In Italy, 67% of respirologists screen patients at night to tailor nocturnal oxygen prescriptions, a practice also reflected in the increased use of portable oxygen devices.  Germany's 2022 healthcare budget allocated USD 36 Billion for medical devices, reflecting substantial investment in respiratory care equipment including portable oxygen concentrators. 

Growth Factors in the Portable Oxygen Concentrators Market

• Rapidly Aging Global Population: According to the European Commission, more than 21.3% of Europe's population is above 65 years of age as of 2023.  As age increases susceptibility to COPD, pneumonia, and other lung disorders, the geriatric demographic is a primary and expanding patient base for portable oxygen therapy devices.
• High COPD Prevalence in Emerging Markets: The WHO estimates that more than 100 million people in China suffer from COPD , creating immense domestic demand for oxygen therapy equipment. The Chinese government allocated USD 1.5 Billion toward medical equipment in 2023 as part of its medical reform agenda.  In Brazil, over 6.3 million people suffer from COPD according to the International Pharmaceutical Federation , representing a substantial addressable market for portable concentrators.
• Medicare Reimbursement Policies Expanding US Adoption: Around 16 million Americans have COPD according to the CDC , and Medicare reimbursement policies have significantly enhanced the affordability and adoption of POCs across the United States. In November 2024, Belluscura secured a USD 4 million credit facility with Sallyport Commercial Finance, combined with Medicare clearance received in October 2024, to launch its DISCOV-R portable oxygen concentrator into the B2B market. 
• Medical Tourism Fueling Demand in Asia Pacific: Malaysia and Thailand are increasingly witnessing medical tourism, thereby increasing the demand for portable oxygen concentrators  in clinical, post-operative, and ambulatory care settings. Tie-ups between global manufacturers and local distributors are accelerating product availability across the region.
• Innovation in Energy Efficiency for Low-Resource Settings: In March 2024, Drive DeVilbiss Healthcare and Sanrai International unveiled the PulmO2 10L Oxygen Concentrator, designed for global use in low-resource settings, offering energy savings of up to 64% compared to traditional models and built to endure harsh clinical environments, supported by the UK government. 

Leading Companies Operating in the Global Portable Oxygen Concentrators Industry:

• Caire Inc. (NGK Spark Plug Co. Ltd)
• Chart Industries Inc.
• Drive Devilbiss Healthcare Limited (Drive International LLC)
• Inogen Inc.
• Invacare Corporation
• Koninklijke Philips N.V.
• Nidek Medical India Pvt Ltd
• O2 Concepts LLC
• Precision Medical Inc. (BioHorizons Inc.)
• Teijin Limited

Portable Oxygen Concentrators Market Report Segmentation:

Breakup By Technology:

• Continuous Flow
• Pulse Flow

Pulse flow represents the leading segment with 69.5% of market share in 2025, owing to its synchronized oxygen delivery that minimizes wastage, lightweight design, extended battery life, and suitability for active, ambulatory patients managing chronic respiratory conditions. 

Breakup By Application:

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Respiratory Distress Syndrome
• Sleep Apnea
• Others

COPD dominates the application segment with a 43.2% market share, driven by the condition's high global prevalence and the prolonged supplemental oxygen therapy requirements of COPD patients, combined with growing awareness of early diagnosis and treatment. 

Breakup By End User:

• Hospitals
• Ambulatory Surgery Centers
• Others

Ambulatory surgery centers hold the largest end user market share, reflecting the growing trend toward outpatient care that is more cost-effective and convenient, where portable oxygen concentrators support pre-operative and post-operative respiratory care for patients with underlying chronic conditions. 

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America holds the leading position with over 38.9% of the market in 2025, supported by a high prevalence of respiratory diseases, well-established healthcare infrastructure, robust research and development culture driven by key industry players, and favorable Medicare reimbursement policies. 

Recent News and Developments in the Portable Oxygen Concentrators Market

• June 2024: Inogen announced the publication of a study in Pulmonary Therapy showing that portable oxygen concentrators improve survival rates and reduce costs compared to other oxygen therapies, based on data from 244,000 patients, confirming POCs' value in improving health outcomes and reducing healthcare costs. 
• August 2024: O2 Concepts announced a new partnership with VGM and Associates, enhancing the VGM Respiratory portfolio by providing members with innovative POC devices from O2 Concepts along with the DNA platform for more effective respiratory care and fleet management. 
• September 2024: Oxymed launched the P2 Portable Oxygen Concentrator in India, weighing 1.98 kg, delivering oxygen with 90-95% purity across five pulse flow settings and offering up to 10 hours of battery life with a double battery. The device is FAA and FDA approved and is supported by home installation and service across 50 cities in India. 
• October 2024: Inogen Inc. introduced the Rove 4 Portable Oxygen Concentrator, featuring a fourth flow setting delivering 840 ml/min of oxygen with up to 5.75 hours of operation in a portable design that enhances ambulatory oxygen therapy for patients. 
• November 2024: Belluscura secured a USD 4 million credit facility with Sallyport Commercial Finance to expand its manufacturing, distribution, and sales efforts, combined with Medicare clearance received in October 2024, enabling the company to launch its DISCOV-R portable oxygen concentrator into the B2B market.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302